University of California San Francisco | About UCSF | UCSF Medical Center
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Stephen M. Rosenthal

Stephen M. Rosenthal, M.D.

Director of Pediatric Endocrinology Clinics
Medical Director of the Child and Adolescent Gender Center

Dr. Stephen M. Rosenthal is program director for Pediatric Endocrinology, director of the Endocrine Clinics, co-director of the Disorders of Sex Development (DSD) Clinic and co-founder of the Pediatric Diabetes Program at UCSF Benioff Children's Hospital. He is also a professor of clinical pediatrics at UCSF.

In addition, Rosenthal conducts research on DSD, transgender health in youth and adolescents, and on pediatric and adolescent Type 1 diabetes. He led an effort to create the Child and Adolescent Gender Center (CAGC), a program that brings together experts from many disciplines to provide comprehensive medical and mental health care, as well as education and advocacy, for gender non-conforming/transgender youth and adolescents. He is co-chair of the CAGC steering committee and medical director of the CAGC.

Rosenthal earned a bachelor's degree at Yale University and a medical degree at Columbia University, where he also completed a residency in pediatrics. He completed a fellowship in pediatric endocrinology at UCSF.

Clinics

Child and Adolescent Gender Center Clinic
400 Parnassus Ave., Second Floor
San Francisco, CA 94143
Appointments: (415) 353-7337

Disorders of Sex
Development Clinic
400 Parnassus Ave., Suite 610
San Francisco, CA 94143
Phone: (415) 353-2200

Endocrinology Clinic
400 Parnassus Ave, Second floor
San Francisco, CA 94143
Phone: (415) 353-7337

Pediatric Diabetes Clinic
1500 Owens St., Suite 300
San Francisco, CA 94158
Phone: (415) 514-6234

Conditions & Treatments

More about Stephen M. Rosenthal

Additional Languages

French

Education

Columbia University 1976

Residencies

Columbia University, Pediatrics 1979

Fellowships

UCSF Medical Center, Endocrinology 1982

Selected Research and Publications

  1. Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial. Diabetologia. 2013 Feb; 56(2):391-400.
  2. Sherer I, Rosenthal SM, Ehrensaft D, Baum J. Child and Adolescent Gender Center: a multidisciplinary collaboration to improve the lives of gender nonconforming children and teens. Pediatr Rev. 2012 Jun; 33(6):273-5.
  3. Cheung CC, Cadnapaphornchai MA, Ranadive SA, Gitelman SE, Rosenthal SM. Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor. Int J Pediatr Endocrinol. 2012; 2012(1):3.
  4. Ranadive SA, Rosenthal SM. Pediatric disorders of water balance. Pediatr Clin North Am. 2011 Oct; 58(5):1271-80, xi-xii.
  5. Aslan IR, Baca EA, Charlton RW, Rosenthal SM. Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl. Int J Pediatr Endocrinol. 2011; 2011:138903.
  6. Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol. 2010 May; 77(5):836-45.
  7. Cho YH, Gitelman S, Rosenthal S, Ambler G. Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis. Int J Pediatr Endocrinol. 2009; 2009:431527.
  8. Ranadive SA, Rosenthal SM. Pediatric disorders of water balance. Endocrinol Metab Clin North Am. 2009 Dec; 38(4):663-72.
  9. Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, Miller WL, Vaisse C. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf). 2009 Sep; 71(3):388-93.
  10. Bremer AA, Ranadive S, Conrad SC, Vallette-Kasic S, Rosenthal SM. Isolated adrenocorticotropic hormone deficiency presenting as an acute neurologic emergency in a peripubertal girl. J Pediatr Endocrinol Metab. 2008 Aug; 21(8):799-803.
  11. Rosenthal SM. Statement 4: therapy should be offered to children with idiopathic short stature (ISS) whose heights are < -2.25 standard deviation (SD) score. Pediatr Endocrinol Rev. 2008 Apr; 5 Suppl 3:847-52.
  12. Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, Youngren JF, Goldfine ID, Weiss WA, Matthay KK, Rosenthal SM. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem. 2007 Dec 15; 102(6):1529-41.
  13. Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency. Pediatr Endocrinol Rev. 2007 May; 4 Suppl 2:252-71.
  14. Bremer AA, Feldman BJ, Iezza G, Clark OH, Rosenthal SM. Report of a hürthle cell neoplasm in a peripubertal girl. Thyroid. 2007 Feb; 17(2):175-8.
  15. Rosenthal SM, Feldman BJ, Vargas GA, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction. Pediatr Endocrinol Rev. 2006 Dec; 4 Suppl 1:66-70.
  16. Gitelman SE, Feldman BJ, Rosenthal SM. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients. Am J Med. 2006 Jul; 119(7 Suppl 1):S54-8.
  17. Huang EA, Feldman BJ, Schwartz ID, Geller DH, Rosenthal SM, Gitelman SE. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr. 2006 Jan; 148(1):128-31.
  18. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005 May 5; 352(18):1884-90.
  19. Tiffin N, Adi S, Stokoe D, Wu NY, Rosenthal SM. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology. 2004 Nov; 145(11):4991-6.
  20. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr. 2003 Oct; 143(4):415-21.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California